Supartz_Sodium_Hyalronate_for_the_Treatment_of_Knee_Osteoathritis_A_Review_of_Efficacy_and_Safety-1.jpg

Effcacy and Safety of Supartz (Sodium Hyaluronate) for the Treatment of Knee Osteoarthritis

Supartz (Sodium Hyalronate) for the Treatment of Knee Osteoathritis: A Review of Efficacy and Safety

Article specifications

This review study was published in 2019 in Journal of Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders (IF2018: 1.02) by American and Japanese specialists. Repeated courses of Supartz are as safe as single courses and have an extremely low risk of infection. Findings from promising initial studies, which suggest that Supartz may improve muscle strength, gait pattern, and balance, should be confirmed in randomized controlled trials.

 

Results

Supartz is an effective and safe treatment for the management of knee OA.57,58 IA-HA is a suitable alternative to systemic pharmacologic treatments (eg, NSAIDs, opioids) in patients who have an inadequate treatment response to these medications or who experience or are at risk for the significant side effects and complications associated with these agents.

Tags: USA Japan Review article 2019 Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders

Hayland Center

© 2018 HYLAND.CENTER ALL RIGHTS RESERVED